BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3796829)

  • 1. Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Kolkin S; Nahman NS; Mendell JR
    Neurology; 1987 Jan; 37(1):147-9. PubMed ID: 3796829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine therapy in chronic inflammatory demyelinating polyradiculoneuropathy--a preliminary report of clinical results in two patients.
    Jongen PJ; Joosten EM; Berden JH; Gabreëls-Festen AA
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):329-32. PubMed ID: 3381292
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.
    Barnett MH; Pollard JD; Davies L; McLeod JG
    Muscle Nerve; 1998 Apr; 21(4):454-60. PubMed ID: 9533779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy.
    Hodgkinson SJ; Pollard JD; McLeod JG
    J Neurol Neurosurg Psychiatry; 1990 Apr; 53(4):327-30. PubMed ID: 2341846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine nephrotoxicity without major organ transplantation.
    Nahman NS; Cosio FG; Kolkin S; Mendell JR; Sharma HM
    Ann Intern Med; 1987 Mar; 106(3):400-2. PubMed ID: 3544994
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic irreversible nephrotoxicity from cyclosporin A.
    Rao KV; Crosson JT; Kjellstrand CM
    Nephron; 1985; 41(1):75-7. PubMed ID: 3897887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for the development of chronic cyclosporine-nephrotoxicity.
    Mihatsch MJ; Steiner K; Abeywickrama KH; Landmann J; Thiel G
    Clin Nephrol; 1988 Apr; 29(4):165-75. PubMed ID: 3284669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of cyclosporine.
    Bennett WM
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1280-5; discussion 1285-7. PubMed ID: 2277136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic relapsing inflammatory demyelinating polyneuropathy by cyclosporin A and plasma exchange. A case report.
    Hefter H; Sprenger KB; Arendt G; Hafner D
    J Neurol; 1990 Aug; 237(5):320-3. PubMed ID: 2230850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine nephropathy after heart and heart-lung transplantation.
    Goldstein J; Thoua Y; Wellens F; Leclerc JL; Vanherweghem JL; Vereerstraeten P; Primo G; Toussaint C
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():973-81. PubMed ID: 3921960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of a nonionic (iopamidol) versus an ionic (diatrizoate) contrast agent in the patient after cardiac transplant with moderate cyclosporine-induced renal insufficiency.
    Denys BG; Reddy PS; Uretsky BF
    Am J Cardiol; 1989 Aug; 64(5):405-6. PubMed ID: 2667306
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine nephrotoxicity and the role of cyclosporine in living-related donor transplantation.
    Paller MS
    Am J Kidney Dis; 1990 Nov; 16(5):414-6. PubMed ID: 2239930
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic inflammatory demyelinating polyradiculoneuropathy of acute onset: relapse after temporary improvement by plasma exchange and longstanding remission by corticosteroid therapy].
    Iwatsubo T; Sakanaka C; Obi T; Takeda K; Sakuta M
    Rinsho Shinkeigaku; 1989 Jul; 29(7):930-2. PubMed ID: 2805518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic inflammatory demyelinating polyradiculoneuropathy].
    Drozdowski W; Czerwińska-Ciechan K; Jankowicz E
    Neurol Neurochir Pol; 1994; 28(6):921-6. PubMed ID: 7870266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment.
    Dyck PJ; O'Brien PC; Oviatt KF; Dinapoli RP; Daube JR; Bartleson JD; Mokri B; Swift T; Low PA; Windebank AJ
    Ann Neurol; 1982 Feb; 11(2):136-41. PubMed ID: 7041788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up.
    Greenberg A; Thompson ME; Griffith BJ; Hardesty RL; Kormos RL; el-Shahawy MA; Janosky JE; Puschett JB
    Transplantation; 1990 Oct; 50(4):589-93. PubMed ID: 2219280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: a prospective randomized study.
    Sobh M; el-Agroudy A; Moustafa F; Harras F; el-Bedewy M; Ghoneim M
    Am J Nephrol; 1995; 15(6):493-9. PubMed ID: 8546171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function and blood pressure in patients treated with cyclosporin A for uveitis.
    Deray G; Le Hoang P; Cacoub P; Aupetit B; Mertani A; Martinez F; Rottembourg J
    Eur J Clin Pharmacol; 1988; 34(6):601-4. PubMed ID: 3169111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.